Taken together, this research reveals the molecular mechanisms of circSLC25A16 on NSCLC glycolysis through miR-488-3p/HIF-1α/LDHA, suggesting the underlying pathogenesis for NSCLC and providing a therapeutic strategy for precise treatment. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.